news

Launch of a "Humanoid Development Project" utilizing physical AI.

Announcement Regarding the Signing of a Naming Rights Sponsorship Agreement for Konoike Sports Park in Nara City

A survey was conducted in Obu City, Aichi Prefecture, regarding the current state of childhood myopia. While approximately 90% of parents intend to take preventative measures, only about 50% actually do so.

Rohto Eye Vision, Japan's only eye care product featuring a BTA formula specifically designed for children's eye inflammation, is now available.

New product launch: "V Rohto Dryguard Premium," an over-the-counter eye drop containing 1% high-molecular-weight chondroitin.

The long-loved "Rohto Pharmaceutical corporate commercial song" has been reborn with an arrangement by world-renowned pianist Hayato Sumino and has begun airing as a time signal in the city.

Kyoto Prefecture's Kizugawa City and Rohto Pharmaceutical Co., Ltd. have signed an agreement regarding the provision of temporary evacuation shelters during disasters.

A wearable medical device for managing symptoms of overactive bladder is set to be launched in the Chinese market.

Elucidation of the involvement of chondroitin sulfate in age-related inflammation of the cornea and conjunctiva

Certified as a "Certified Health & Productivity Management Outstanding Organization (White 500)" for the 9th time in 6 consecutive years

Rohto Pharmaceutical Group conducts multifaceted awareness activities in conjunction with World Glaucoma Week

Development of a medical consultation recommendation evaluation index based on a survey of menstrual-associated symptoms, with menstrual pain as the main complaint

Rohto Pharmaceutical has released its "2025 Fertility White Paper." The key to solving the problem is to "gain accurate fertility knowledge early on" and "get support before you conceive a child."

From "reading" to "eating" academic papers: Tohoku University's "Academy Recipes®" and Rohto Pharmaceutical's "ROHTO RECIPE" collaboration menu now available

Announcement of strengthened collaboration with Reimei Co., Ltd. toward practical application in the field of Regenerative medicine

Launch of Rohto Alguard Epinastine Eye Drops, a new allergy eye drop containing the same active ingredient, epinastine hydrochloride, as the prescription version.

Human Life Code and Rohto Pharmaceutical Collaborate to Manufacture Investigational Products for Phase III Clinical Trials

Certified as Silver+ (Plus) by "Sports Yell Company 2026"

A limited number of collaboration products between eye drops "ROHTO Zi®" and "NARUTO Shippuden" will be released!

The "MELANO CC ®+" series is born. The new "MELANO CC + AZmask" with pure vitamin C and pure azelaic acid is launched.

Regarding the issue of the old DRX brand website URL being redirected to a fraudulent site.

Initiatives to Ensure Safety in Cell Therapy

Notice of changes to packaging specifications due to environmental considerations

Publication of "Rohto Health White Paper 2025"

Please purchase from authorized Obagi retailers.

Initiatives to Ensure Safety in Cell Therapy

Setting new health and productivity management indicators for 2030

Report and Apology Regarding the Consumer Affairs Agency's Corrective Order

Revision of the "Multi-Stakeholder Policy"

Report and Apology Regarding the Consumer Affairs Agency's Corrective Order

Rohto Group formulates "Basic Policy on Customer Harassment"

Please be careful of suspicious investment solicitations related to our company.

Beware of counterfeit "Lush Rich" products

Please be aware of suspicious e-mails purporting to be from our company's employees and directors

Beware of counterfeit Obagi C25 Serum NEO products

Information about the pigments used in our sunscreen products

Notice of revision of precautions for use of eye drops (over-the-counter drugs) containing sodium sulfamethoxazole

Please be aware of suspicious e-mails purporting to be from our company's employees and directors

Regarding some reports about our company

On the occasion of our 125th anniversary, our corporate slogan and logo design have been renewed.

We are pleased to announce the 19th recipient of Rohto Prize, a research fund specializing in Japanese Association of Geriatric Dermatology Research Fund skin.

Announcement of the public call for applications for the "Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical)"

The 16th recipients of the Rohto Women's Health Science Research Award have been announced

The recipients of the 30th ROHTO AWARD research grant have been decided.

Recipients of the "Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical)" have been decided

Announcement of the public call for applications for the "Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical)"

We are pleased to announce the 18th recipient of Rohto Prize, a research fund specializing in Japanese Association of Geriatric Dermatology Research Fund skin.

The 4th Rohto Regenerative medicine Forum was held

The 15th recipients of the Rohto Women's Health Science Research Award have been announced

The recipients of the 29th ROHTO AWARD research grant have been decided.

Recipients of the "Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical)" have been decided

Announcement of the public call for applications for the "Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical)"

We are pleased to announce the 17th recipient of Rohto Prize, a research fund specializing in Japanese Association of Geriatric Dermatology Research Fund skin.

The 3rd Rohto Regenerative medicine Forum was held

The 14th recipients of the Rohto Women's Health Science Research Award have been announced

The recipients of the 28th ROHTO AWARD research grant have been decided.

Recipients of the "Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical)" have been decided

Announcement of the public call for applications for the "Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical)"

We are pleased to announce the 16th recipient of Rohto Prize, a research fund specializing in Japanese Association of Geriatric Dermatology Research Fund skin.

The recipients of the 2021 Rohto Women's Health Science Research Award have been announced